Nektar Therapeutics Files 8-K on Financials
Ticker: NKTR · Form: 8-K · Filed: May 8, 2025 · CIK: 906709
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Nektar Therapeutics dropped an 8-K on May 8th detailing their financial results. Check it out!
AI Summary
Nektar Therapeutics filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date of change both being May 8, 2025. The company is incorporated in Delaware and headquartered in San Francisco, California.
Why It Matters
This 8-K filing provides an update on Nektar Therapeutics' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Nektar Therapeutics (company) — Registrant
- May 8, 2025 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
- San Francisco, California (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed and what is the earliest event date reported?
The report was filed on May 8, 2025, and the earliest event date reported is also May 8, 2025.
Where is Nektar Therapeutics' principal executive office located?
Nektar Therapeutics' principal executive office is located at 455 Mission Bay Boulevard South, San Francisco, California 94158.
What is Nektar Therapeutics' IRS Employer Identification Number (EIN)?
Nektar Therapeutics' IRS Employer Identification Number is 94-3134940.
What is the Commission File Number for Nektar Therapeutics?
The Commission File Number for Nektar Therapeutics is 0-24006.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding NEKTAR THERAPEUTICS (NKTR).